Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2020. Start Trial.
Date Value
October 30, 2026 3.654
October 29, 2026 4.175
October 28, 2026 4.178
October 27, 2026 3.966
October 26, 2026 3.560
October 23, 2026 3.869
October 22, 2026 3.671
October 21, 2026 3.654
October 20, 2026 3.608
October 19, 2026 3.564
October 16, 2026 3.812
October 15, 2026 3.906
October 14, 2026 3.147
October 13, 2026 3.189
October 12, 2026 3.462
October 09, 2026 3.602
October 08, 2026 3.973
October 07, 2026 4.197
October 06, 2026 4.248
October 05, 2026 4.443
October 02, 2026 4.634
October 01, 2026 4.469
September 30, 2026 4.601
September 29, 2026 4.734
September 28, 2026 4.863
Date Value
September 25, 2026 4.952
September 24, 2026 5.054
September 23, 2026 5.027
September 22, 2026 5.179
September 21, 2026 5.243
September 18, 2026 5.204
September 17, 2026 5.111
September 16, 2026 5.065
September 15, 2026 4.902
September 14, 2026 4.985
September 11, 2026 5.044
September 10, 2026 5.040
September 09, 2026 5.145
September 08, 2026 5.287
September 04, 2026 5.376
September 03, 2026 5.296
September 02, 2026 5.302
September 01, 2026 5.069
August 31, 2026 5.344
August 28, 2026 5.777
August 27, 2026 6.156
August 26, 2026 6.057
August 25, 2026 6.231
August 24, 2026 5.885
August 21, 2026 5.707

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Amgen, Inc. 21.55
Altimmune, Inc. 0.8366
Protalix Biotherapeutics, Inc. 2.922
Taysha Gene Therapies, Inc. 3.469
Agenus, Inc. --

Price to Book Value Related Metrics

PS Ratio 37.67
PEG Ratio -0.1158
Price 0.4112
Earnings Yield -119.1%
Market Cap 114.23M
PEGY Ratio -0.1158